Systematic pan-cancer analysis reveals the prognostic and immunological roles of ectonucleoside triphosphate diphosphohydrolase 6

Figure 4 The correlation between ectonucleoside triphosphate diphosphohydrolase 6 expression and genetic alterations, as well as genomic instability. A: Pan-cancer analyses of genomic changes in ectonucleoside triphosphate diphosphohydrolase 6 (ENTPD6) expression were conducted, including analyses of mutations, amplifications, and deep deletions; B: Genetic alterations of ENTPD6, including missense, frameshift deletion, and splice site mutations; C: ENTPD6 expression in different copy number alteration categories; D: The correlation between copy number alteration and ENTPD6 expression. CAN: Copy number alteration; VUS: Variant of uncertain significance; ENTPD6: Ectonucleoside triphosphate diphosphohydrolase 6; RSEM: RNA-Seq by Expectation Maximization; GSTIC: Genomic Identification of Significant Targets in Cancer.